EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effectiveness and Tolerability of Anti-Tumor Necrosis Factor Alpha Therapy in Refractory Intestinal Behçet’s Disease: A Large Single-Center Study

Ji Young Chang iD, Jiwoo Kim iD, Soo Jung Park iD, Jae Jun Park iD, Tae Il Kim iD, Jae Hee Cheon iD, Jihye Park iD

Gut and Liver · 15.03.2026 · 20 (2) · 305-314

DOI: 10.5009/gnl250346 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gut and Liver, online erschienen am 27.11.2025. Verfasst von Ji Young Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Promotion Medicine, Ewha Womans University Seoul Hospital, Seoul, Korea. Hauptthemen laut MEDLINE: Behcet Syndrome, Tumor Necrosis Factor-alpha, Intestinal Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Industry Development Institute, Ministry of Health and Welfare, Wooduk Scholarship Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Behcet SyndromeTumor Necrosis Factor-alphaIntestinal DiseasesHumansFemaleMaleAdultTreatment OutcomeMiddle AgedRecurrenceInfliximabRemission InductionRetrospective StudiesRepublic of KoreaYoung AdultAdrenal Cortex Hormones

Stichwörter der Autor:innen

Behcet diseaseRecurrenceTumor necrosis factor inhibitors

Substanzen

Tumor Necrosis Factor-alphaInfliximabAdrenal Cortex Hormones

Autor:innen und Institutionen

  • Department of Health Promotion Medicine, Ewha Womans University Seoul Hospital, Seoul, Korea.
  • Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
  • Institute of Gastroenterology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Inflammatory Bowel Disease Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.

ORCID-Profile: Ji Young Chang, Jiwoo Kim, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon, Jihye Park

Förderung

  • Korea Health Industry Development Institute
  • Ministry of Health and Welfare
  • Wooduk Scholarship Foundation

Zitieren

APA

Chang, J. Y., Kim, J., Park, S. J., Park, J. J., Kim, T. I., Cheon, J. H., & Park, J. (2026). Effectiveness and Tolerability of Anti-Tumor Necrosis Factor Alpha Therapy in Refractory Intestinal Behçet’s Disease: A Large Single-Center Study. Gut and Liver, 20(2), 305-314. https://doi.org/10.5009/gnl250346

Vancouver

Chang JY, Kim J, Park SJ, Park JJ, Kim TI, Cheon JH, et al. Effectiveness and Tolerability of Anti-Tumor Necrosis Factor Alpha Therapy in Refractory Intestinal Behçet’s Disease: A Large Single-Center Study. Gut and Liver. 2026;20(2):305-314. doi:10.5009/gnl250346

BibTeX
@article{Chang2026,
  author = {Chang, Ji Young and Kim, Jiwoo and Park, Soo Jung and Park, Jae Jun and Kim, Tae Il and Cheon, Jae Hee and Park, Jihye},
  title = {Effectiveness and Tolerability of Anti-Tumor Necrosis Factor Alpha Therapy in Refractory Intestinal Behçet’s Disease: A Large Single-Center Study},
  journal = {Gut and Liver},
  year = {2026},
  volume = {20},
  number = {2},
  pages = {305--314},
  doi = {10.5009/gnl250346}
}
Kostenlos starten →